Proteomics in Pancreatic Cancer Research

Abstract EN

Pancreatic cancer is a highly aggressive malignancy with a poor prognosis and deeply affects the life of people.

Therefore, the earlier diagnosis and better treatments are urgently needed.

In recent years, the proteomic technologies are well established and growing rapidly and have been widely applied in clinical applications, especially in pancreatic cancer research.

In this paper, we attempt to discuss the development of current proteomic technologies and the application of proteomics to the field of pancreatic cancer research.

This will explore the potential perspective in revealing pathogenesis, making the diagnosis earlier and treatment.